Verana Health Stock
Verana Health offers a platform for life science innovation that utilizes regulatory-grade specialty data sets
Sign up today and learn more about Verana Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Verana Health Stock
Innovation in healthcare is hindered by the time and cost of bringing new therapeutics and devices to market. Verana Health, previously known as DigiSight Technologies, is building a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets. This platform initially utilizes real-world data from the world’s largest clinical database in ophthalmology, representing billions of data points, to deeply understand patient needs and to optimize drug and device development from clinical research through to post-commercialization. To learn more, visit www.veranahealth.com.
Funding History
February 2015 | $7.8M |
---|---|
July 2018 | $30.0M |
Management
Senior Vice President, Technology
Nitin Karandikar
Director
Mark Blumenkranz
Chief Executive Officer
Douglas Foster
Press
linkedin - Apr, 8 2024
Verana Health CEO featured in Authority Magazine | Verana Health posted on the topictradingview - Apr, 8 2024
Verana Health Developing Qdata® Dry Eye Disease, the Largest Real-World Dataset of its Kindlinkedin - Apr, 8 2024
Verana Health on LinkedIn: How AI is Helping Transform Neurodegenerative Disease Treatment Right Nowmedium - Apr, 8 2024
Health Tech: Sujay Jadhav Of Verana Health On How Their Technology Can Make An Important Impact On…linkedin - Apr, 8 2024
Verana Health on LinkedIn: #ai #rwe